|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/12/16 Idt Corp 10-Q 10/31/16 68:3.3M Edgar Agents LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 307K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 22K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 22K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 19K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 19K
12: R1 Document and Entity Information HTML 39K
13: R2 Consolidated Balance Sheets HTML 125K
14: R3 Consolidated Balance Sheets (Parenthetical) HTML 42K
15: R4 Consolidated Statements of Income (Unaudited) HTML 78K
16: R5 Consolidated Statements of Comprehensive Income HTML 43K
(Unaudited)
17: R6 Consolidated Statements of Cash Flows (Unaudited) HTML 115K
18: R7 Basis of Presentation HTML 24K
19: R8 Zedge Spin-Off HTML 28K
20: R9 Investment in Cornerstone Pharmaceuticals, Inc. HTML 28K
21: R10 Marketable Securities HTML 58K
22: R11 Fair Value Measurements HTML 40K
23: R12 Derivative Instruments HTML 39K
24: R13 Equity HTML 49K
25: R14 Earnings Per Share HTML 34K
26: R15 Revolving Credit Loan Payable HTML 24K
27: R16 Accrued Severance Expense HTML 21K
28: R17 Accumulated Other Comprehensive Loss HTML 29K
29: R18 Business Segment Information HTML 44K
30: R19 Commitments and Contingencies HTML 45K
31: R20 Other Income (Expense), Net HTML 26K
32: R21 Income Taxes HTML 23K
33: R22 Recently Issued Accounting Standard Not Yet HTML 32K
Adopted
34: R23 Zedge Spin-Off (Tables) HTML 23K
35: R24 Marketable Securities (Tables) HTML 58K
36: R25 Fair Value Measurements (Tables) HTML 29K
37: R26 Derivative Instruments (Tables) HTML 29K
38: R27 Equity (Tables) HTML 33K
39: R28 Earnings Per Share (Tables) HTML 33K
40: R29 Accumulated Other Comprehensive Loss (Tables) HTML 25K
41: R30 Business Segment Information (Tables) HTML 34K
42: R31 Commitments and Contingencies (Tables) HTML 25K
43: R32 Other Income (Expense), Net (Tables) HTML 24K
44: R33 Zedge Spin-Off (Details) HTML 26K
45: R34 Investment in Cornerstone Pharmaceuticals, Inc. HTML 76K
(Details)
46: R35 Marketable Securities (Details) HTML 64K
47: R36 Marketable Securities (Details 1) HTML 34K
48: R37 Marketable Securities (Details 2) HTML 39K
49: R38 Marketable Securities (Details Textual) HTML 27K
50: R39 Fair Value Measurements (Details) HTML 30K
51: R40 Fair Value Measurements (Details Textual) HTML 22K
52: R41 Derivative Instruments (Details) HTML 21K
53: R42 Equity (Details) HTML 59K
54: R43 Equity (Details Textual) HTML 52K
55: R44 Earnings Per Share (Details) HTML 32K
56: R45 Earnings Per Share (Details 1) HTML 21K
57: R46 Revolving Credit Loan Payable (Details) HTML 46K
58: R47 Accrued Severance Expense (Details) HTML 26K
59: R48 Accumulated Other Comprehensive Loss (Details) HTML 33K
60: R49 Business Segment Information (Details) HTML 39K
61: R50 Business Segment Information (Details Textual) HTML 19K
62: R51 Commitments and Contingencies (Details) HTML 28K
63: R52 Commitments and Contingencies (Details Textual) HTML 38K
64: R53 Other Income (Expense), Net (Details) HTML 33K
65: R54 Income Taxes (Details) HTML 23K
67: XML IDEA XML File -- Filing Summary XML 117K
66: EXCEL IDEA Workbook of Financial Reports XLSX 58K
6: EX-101.INS XBRL Instance -- idt-20161031 XML 813K
8: EX-101.CAL XBRL Calculations -- idt-20161031_cal XML 135K
9: EX-101.DEF XBRL Definitions -- idt-20161031_def XML 362K
10: EX-101.LAB XBRL Labels -- idt-20161031_lab XML 914K
11: EX-101.PRE XBRL Presentations -- idt-20161031_pre XML 581K
7: EX-101.SCH XBRL Schema -- idt-20161031 XSD 124K
68: ZIP XBRL Zipped Folder -- 0001213900-16-019309-xbrl Zip 93K
 | Download this zipped .zip folder |
| Files: | idt-20161031.xml idt-20161031.xsd idt-20161031_cal.xml idt-20161031_def.xml idt-20161031_lab.xml idt-20161031_pre.xml |